MAO A/HSP90-IN-2 is a dual inhibitor of HSP90 and MAO A, exhibiting potent antitumor activity by upregulating HSP70 expression, downregulating HER2 and phosphorylated AKT expression, and suppressing IFN-γ-induced PD-L1 upregulation in GL26 cells. It inhibits the growth of both temozolomide-sensitive and temozolomide-resistant glioblastoma (GBM) cells, as well as colon cancer, leukemia, and non-small cell lung cancer cells, demonstrating potential in suppressing tumor immune evasion.